Delivery Order SPE2DP16D0002-SPE2DP21F0891
- Not listed
- The U.S. Defense Logistics Agency Troop Support Medical awarded a $370,440.00 Firm Fixed Price delivery order contract to the Canadian Commercial Corporation, a Crown corporation owned by the Government of Canada, to provide Pyridostigmine Bromide. This contract does not have a set-aside designation. The Canadian Commercial Corporation has previously acted as a prime contractor to the Department of Defense, providing a variety of goods and services including aviation and vehicle components,...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency Troop Support Medical to the Canadian Commercial Corporation, a Crown corporation owned by the Government of Canada that facilitates military exports and international contracting opportunities for Canadian companies. The contract, valued at $356,130.00, is for the delivery of pyridostigmine bromide, a pharmaceutical used for the treatment of myasthenia gravis and as a pretreatment for nerve agent...
- This is a Firm Fixed Price Delivery Order contract awarded by the Defense Logistics Agency Troop Support Medical to the Canadian Commercial Corporation, a Crown corporation owned by the Government of Canada. The contract is for the procurement of PYRIDOSTIGMINE BROM, a pharmaceutical product, with a potential value of $337,532.10. The contract has no set-aside designation. Canadian Commercial Corporation, as the prime contractor, has provided a wide range of goods and services to U.S. federal...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency Troop Support Medical to Canadian Commercial Corporation, a Crown corporation owned by the Government of Canada that facilitates military exports and international contracting opportunities for Canadian companies. The contract is for the supply of Pyridostigmine Bromide, a drug used to treat nerve agent exposure, with a potential value of $370,440.00 and a completion date of January 15, 2021. The...
- This federal contract award was issued by the Defense Logistics Agency Troop Support Medical to Canadian Commercial Corporation, a Crown corporation owned by the Government of Canada, for the delivery of pyridostigmine bromide with a potential value of $354,387.60. The contract is a Firm Fixed Price Delivery Order that was awarded on April 15, 2020 and has a completion date of July 14, 2020. There was no set-aside designation used for this award. Canadian Commercial Corporation has previously...
- This is a $356,130.00 firm fixed price delivery order awarded by the Defense Logistics Agency Troop Support Medical to Canadian Commercial Corporation, a Crown corporation owned by the Government of Canada that acts as a prime contractor to facilitate military exports and international contracting opportunities for Canadian companies. The contract is for the provision of pyridostigmine bromide, a pharmaceutical used for nerve agent antidote. The award does not have a set-aside designation....
- This is a delivery order contract (SPE2DP16D0002|0002) awarded by the Defense Logistics Agency (DLA) to the Canadian Commercial Corporation (CCC), a Crown corporation owned by the Government of Canada, for the procurement of pyridostigmine bromide, a drug used to treat nerve agent exposure. The contract has a ceiling value of $342,270.00 and a period of performance ending on December 2, 2016. It is a firm fixed-price contract with no set-aside designation. CCC serves as a prime contractor and...
- The Defense Logistics Agency Troop Support Medical awarded a $368,730 firm fixed price delivery order contract to the Canadian Commercial Corporation for the procurement of 8508348591 pyridostigmine bromide. As the parent company of the awardee, the contract will ultimately be fulfilled by the Government of Canada. No set-aside provisions were applied to this award placed under an unspecified existing vehicle held by the Canadian Commercial Corporation. Performance will occur at the specified...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Canadian Commercial Corporation, a Crown corporation owned by the Government of Canada. The $166,000.00 firm fixed price contract is for the provision of other medical supplies. There is no set-aside designation for this contract. Canadian Commercial Corporation has provided a wide range of goods and services to U.S. federal agencies, particularly the Department of Defense, through the DLA,...
- The Defense Logistics Agency Troop Support Medical has awarded a $1,951.49 firm fixed price delivery order to the Canadian Commercial Corporation for place of performance in Ottawa, Ontario, Canada. As the prime contractor owned by the Government of Canada, Canadian Commercial Corporation will provide unspecified medical supplies and pharmaceuticals to the agency by the January 2024 completion date. This order was issued without a set-aside designation under the company's existing contracting...
- SPE2DP16D0002Indefinite Delivery Contract
- SPE2DP16D0002-SPE2DP21F0891Delivery Order
This is a delivery order contract awarded by the Defense Logistics Agency Troop Support Medical to the Canadian Commercial Corporation, a Crown corporation owned by the Government of Canada. The contract, valued at $370,440.00, is for the delivery of the pharmaceutical product pyridostigmine bromide and does not have a set-aside designation. Canadian Commercial Corporation is the prime contractor and has a history of providing a wide range of goods and services to U.S. federal agencies, particularly the Department of Defense, including aviation and vehicle components, logistical supplies, specialized equipment, ammunition, medical supplies, and research & development services. This delivery order is likely part of a larger indefinite delivery vehicle contract held by Canadian Commercial Corporation to provide various products and services to the U.S. government.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $370.4k | 12/1/20 |